Ann D. Rhoads

CIK: 0001250252

Transaction Breakdown

Open Market Buys (P)1 (2.6%)

High conviction signal

Open Market Sales (S)5 (13.2%)

Position reduction

Option Exercises (M)11 (28.9%)

Derivative conversions

Awards (A)19 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (5.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (4)

QDEL

QuidelOrtho Corp

Director

GMED

GLOBUS MEDICAL INC

Director

RPTX

Repare Therapeutics Inc.

Director

ITOS

iTeos Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (38 total)

QDEL
QuidelOrtho Corp
Jun 25, 2026
Award(A)
Restricted Stock Units (Converted)
Direct
3.7K shares-
QDEL
QuidelOrtho Corp
Jun 25, 2026
Award(A)
Restricted Stock Units (Premium)
Direct
369 shares-
QDEL
QuidelOrtho Corp
Jun 25, 2026
Award(A)
Restricted Stock Units (Equity Grant)
Direct
15.5K shares-
GMED
GLOBUS MEDICAL INC
Jun 4, 2026
Exercise(M)
Direct
25K shares at avg. $26.27$657K
QDEL
QuidelOrtho Corp
May 29, 2026
Exercise(M)
Restricted Stock Units (Equity Grant)
Direct
6.8K shares-
QDEL
QuidelOrtho Corp
May 29, 2026
Award(A)
Direct
6.8K shares-
QDEL
QuidelOrtho Corp
May 22, 2026
Award(A)
Direct
234 shares-
QDEL
QuidelOrtho Corp
May 22, 2026
Award(A)
Direct
1.2K shares-
QDEL
QuidelOrtho Corp
May 22, 2026
Exercise(M)
Restricted Stock Units (Premium)
Direct
234 shares-
QDEL
QuidelOrtho Corp
May 22, 2026
Exercise(M)
Restricted Stock Units (Converted)
Direct
1.2K shares-
RPTX
Repare Therapeutics Inc.
Jan 28, 2026
Disposition(D)
Direct
4K shares-
GMED
GLOBUS MEDICAL INC
Jan 21, 2026
Award(A)
Stock Option (Right to Buy Class A Common Stock)
Direct
15K shares-
QDEL
QuidelOrtho Corp
Dec 10, 2025
Purchase(P)
Direct
750 shares at avg. $28.27$21K
GMED
GLOBUS MEDICAL INC
Nov 10, 2025
Sale(S)
Direct
2K shares at avg. $85.00$170K
GMED
GLOBUS MEDICAL INC
Nov 7, 2025
Sale(S)
Direct
8K shares at avg. $81.00$648K
GMED
GLOBUS MEDICAL INC
Sep 15, 2025
Sale(S)
Direct
10K shares at avg. $58.46$585K
ITOS
iTeos Therapeutics, Inc.
Aug 29, 2025
Disposition(D)
Stock Option (Right to Buy)
Direct
27.2K shares-
QDEL
QuidelOrtho Corp
May 29, 2025
Award(A)
Restricted Stock Units (Converted)
Direct
1.6K shares-
QDEL
QuidelOrtho Corp
May 29, 2025
Award(A)
Restricted Stock Units (Equity Grant)
Direct
6.8K shares-
QDEL
QuidelOrtho Corp
May 29, 2025
Award(A)
Restricted Stock Units (Premium)
Direct
325 shares-
QDEL
QuidelOrtho Corp
May 29, 2025
Award(A)
Restricted Stock Units (Equity Grant)
Direct
6.8K shares-
QDEL
QuidelOrtho Corp
May 29, 2025
Award(A)
Restricted Stock Units (Converted)
Direct
1.6K shares-
QDEL
QuidelOrtho Corp
May 29, 2025
Award(A)
Restricted Stock Units (Premium)
Direct
325 shares-
QDEL
QuidelOrtho Corp
May 24, 2025
Award(A)
Direct
109 shares-
QDEL
QuidelOrtho Corp
May 24, 2025
Exercise(M)
Restricted Stock Units (Converted)
Direct
546 shares-

		Type	Shares	Price		Ownership
Jun 25, 2026	QDEL QuidelOrtho Corp	Award(A) Restricted Stock Units (Converted)	3,698	-	-	Direct
Jun 25, 2026	QDEL QuidelOrtho Corp	Award(A) Restricted Stock Units (Premium)	369	-	-	Direct
Jun 25, 2026	QDEL QuidelOrtho Corp	Award(A) Restricted Stock Units (Equity Grant)	15,532	-	-	Direct
Jun 4, 2026	GMED GLOBUS MEDICAL INC	Exercise(M)	25,000	$26.27	$656,750	Direct
May 29, 2026	QDEL QuidelOrtho Corp	Exercise(M) Restricted Stock Units (Equity Grant)	6,829	-	-	Direct
May 29, 2026	QDEL QuidelOrtho Corp	Award(A)	6,829	-	$0	Direct
May 22, 2026	QDEL QuidelOrtho Corp	Award(A)	234	-	$0	Direct
May 22, 2026	QDEL QuidelOrtho Corp	Award(A)	1,173	-	$0	Direct
May 22, 2026	QDEL QuidelOrtho Corp	Exercise(M) Restricted Stock Units (Premium)	234	-	-	Direct
May 22, 2026	QDEL QuidelOrtho Corp	Exercise(M) Restricted Stock Units (Converted)	1,173	-	-	Direct
Jan 28, 2026	RPTX Repare Therapeutics Inc.	Disposition(D)	4,000	-	$0	Direct
Jan 21, 2026	GMED GLOBUS MEDICAL INC	Award(A) Stock Option (Right to Buy Class A Common Stock)	15,000	-	-	Direct
Dec 10, 2025	QDEL QuidelOrtho Corp	Purchase(P)	750	$28.27	$21,206	Direct
Nov 10, 2025	GMED GLOBUS MEDICAL INC	Sale(S)	2,000	$85.00	$170,000	Direct
Nov 7, 2025	GMED GLOBUS MEDICAL INC	Sale(S)	8,000	$81.00	$648,000	Direct
Sep 15, 2025	GMED GLOBUS MEDICAL INC	Sale(S)	10,000	$58.46	$584,600	Direct
Aug 29, 2025	ITOS iTeos Therapeutics, Inc.	Disposition(D) Stock Option (Right to Buy)	27,178	-	-	Direct
May 29, 2025	QDEL QuidelOrtho Corp	Award(A) Restricted Stock Units (Converted)	1,626	-	-	Direct
May 29, 2025	QDEL QuidelOrtho Corp	Award(A) Restricted Stock Units (Equity Grant)	6,829	-	-	Direct
May 29, 2025	QDEL QuidelOrtho Corp	Award(A) Restricted Stock Units (Premium)	325	-	-	Direct
May 29, 2025	QDEL QuidelOrtho Corp	Award(A) Restricted Stock Units (Equity Grant)	6,829	-	-	Direct
May 29, 2025	QDEL QuidelOrtho Corp	Award(A) Restricted Stock Units (Converted)	1,626	-	-	Direct
May 29, 2025	QDEL QuidelOrtho Corp	Award(A) Restricted Stock Units (Premium)	325	-	-	Direct
May 24, 2025	QDEL QuidelOrtho Corp	Award(A)	109	-	-	Direct
May 24, 2025	QDEL QuidelOrtho Corp	Exercise(M) Restricted Stock Units (Converted)	546	-	-	Direct

1-25 of 38 transactions

About RHOADS ANN D

RHOADS ANN D (SEC CIK 0001250252) files insider reports with the SEC as Director of QuidelOrtho Corp (QDEL), Director of GLOBUS MEDICAL INC (GMED) and Director of Repare Therapeutics Inc. (RPTX). Signal8 also holds filings tied to 1 other company.

Signal8 holds 18 ownership filings by RHOADS ANN D, all Form 4s, filed between Sep 17, 2024 and Jun 29, 2026. Those filings report 38 transactions, from Sep 13, 2024 to Jun 25, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on RHOADS ANN D's filings is in SAN DIEGO, CA.

Recent filings by RHOADS ANN D

Jun 25, 2026: Grants or awards of QDEL derivative securities (3 lines, Form 4, code A).
Jun 4, 2026: Option exercise of GMED shares (Form 4, code M).
May 29, 2026: Option exercise of QDEL derivative securities (Form 4, code M).
May 29, 2026: Grant or award of QDEL shares (Form 4, code A).
May 22, 2026: Grants or awards of QDEL shares (2 lines, Form 4, code A).

Other insiders filing for QuidelOrtho Corp (QDEL)

Siegrist Jonathan Philip, EVP of R&D & CTO
Bowman Ronald Lee, Chief Human Resources Officer
Hanson Bryan Michael, EVP Global Port. Mgmt & Mkting
Young Micah W, Chief Financial Officer
WIDDER KENNETH J, Director
Huennekens R Scott, Director

How to read Form 4 transaction codes